RussellPachynskiMD
Oncology • Saint Louis, MOGenitourinary Oncology, Hematologic Oncology
Associate Professor of Medicine Division of Oncology
Dr. Pachynski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Washington University School of Medicine
660 S Euclid Ave
Saint Louis, MO 63110Phone+1 314-286-2341- Is this information wrong?
Summary
- I have experience and expertise in tumor immunology and immunotherapy in the GU malignancies, with a focus on prostate cancer. My lab studies leukocyte trafficking with a goal of favorable modulation in the context of the tumor microenvironment for therapeutic purposes.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2006 - 2011- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2003 - 2005
University of Wisconsin School of Medicine & Public HealthClass of 2003
Stanford UniversityB.S., Biology, 1990 - 1994
Certifications & Licensure
MO State Medical License 2014 - 2025
CA State Medical License 2004 - 2024
Awards, Honors, & Recognition
- Research Scholar Grant American Cancer Society, 2023
- Prostate Cancer Foundation Team Challenge Award 2016
- Kimmel Scholar Award 2016
- Join now to see all
Clinical Trials
- Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer Start of enrollment: 2018 Sep 14
Publications & Presentations
PubMed
- Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S...Mamta Parikh, Catherine Tangen, Maha H A Hussain, Shilpa Gupta, Sam Callis, Yeonjung Jo, Andrea Harzstark, Channing J Paller, Saby George, Matthew R Zibelman, Heather ...> ;European Urology Oncology. 2024 Mar 23
- High dimensional analyses reveal IL-15 enhances activation of Sipuleucel-T lymphocyte subsets and reverses immunoresistance.Saeed, M., Peng, B., Kim, K., Rawat, K., Kuehm, L., Siegel, Z., Borkowski, A., Habib, N., Van Tine, B., Sheikh, N., Tuyen, V., Thorek, D., Fehniger, T., Pachynski, R.> ;Cancer Immunology Research. 2024 Feb 26
- A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC).David R Wise, Russell K Pachynski, Samuel R Denmeade, Rahul R Aggarwal, Jiehui Deng, Victor Adorno Febles, Arjun V Balar, Minas P Economides, Cynthia Loomis, Shanmugap...> ;Prostate Cancer and Prostatic Diseases. 2024 Feb 10
- Join now to see all
Press Mentions
BostonGene Touts Prostate Cancer Research ResultsJuly 29th, 2021- BostonGene Announces Publication in Clinical Cancer Research Identifying the Cellular Features and Gene Expression Characteristics Underlying MRI Visibility in Prostate CancerJuly 28th, 2021
Jounce Therapeutics to Present Two Posters from the JTX-4014 and Vopratelimab Programs at the Society for Immunotherapy of Cancer's (SITC) 34th Annual MeetingOctober 1st, 2019- Join now to see all
Professional Memberships
- Member
- Member
- Society for Immunotherapy of Cancer (SITC)Member
Hospital Affiliations
Barnes-Jewish HospitalSaint Louis, Missouri- Barnes-Jewish West County HospitalSaint Louis, Missouri
Siteman Cancer CenterSaint Louis, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
